Cited by 3Glioma Diagnosis and TreatmentCancer survivorship and careClinical practice guidelines implementation

Congress of Neurological Surgeons systematic review and evidence-based guidelines for the treatment of adults with progressive glioblastoma update: introduction and methods

Olson, Jeffrey J.·2022·Journal of Neuro-Oncology

Abstract

Introduction The management of glioblastoma at the time of progression is an important facet of all physicians involved in neuro-oncology. This is an update of the evidence-based guidelines for management of progressive glioblastoma published by the Congress of Neurological Surgeons and American Association of Neurological Surgeons in 2014.Methods The medical literature from July 1, 2012 through March 31, 2019 was searched in MEDLINE® and Embase® and the Cochrane Database of Systematic Reviews, Cochrane Controlled Trials Registry, and Cochrane Database of Abstracts of Reviews of Effects to determine if information was available to update, modify or create new recommendations related to imaging, cytoreductive surgery, neuropathology, radiotherapy, cytotoxic chemotherapy, targeted therapy, and immunotherapy.Results The writing group utilized the information from the updated literature search to formulate recommendations that were exclusively evidence based and not founded on potentially biased consensus or expert opinion.Conclusion The series of guideline documents provides an update of the information and recommendations that could be derived in the 2014 version. It sets a benchmark as to what we really know about the management of this difficult disease. It also provides clues to key investigations that are necessary to move us toward truly effective disease control.

Integrity signals

Registry

Crossref · 10.1007/s11060-021-03850-3

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The largest and most significant performance improvement (33%, p < 7 × 10−60) was noted for the tumor core (TC) sub-compartment.

    “Notably, the largest and most significant improvement (33%, p < 7 × 10−60) is noted for the TC sub-compartment, which is surgically actionable and not a trivial sub-compartment to delineate accurately43,44.”

The citation lists haven’t been fetched yet

References 14 · Cited by 3

Authors
Olson, J. J.
Affiliations
Emory University (US)
Corresponding author
Olson, Jeffrey J.
Venue
Journal of Neuro-Oncology
Published
2021-10-25
Volume
158
Issue
2
Pages
133-137
ISSN
  • 0167-594X (ISSN-L)
  • 1573-7373
OpenAlex
W3210570019
Cited by
3
References
14
Citations by year
2024: 1 · 2022: 2
FWCI
0.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Neuro-Oncology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Genetics › Glioma Diagnosis and Treatment
  • Health Sciences › Medicine › Oncology › Cancer survivorship and care
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
Keywords
evidence-based clinical guidelines, cytoreductive surgery, radiotherapy, cytotoxic chemotherapy, targeted therapy, immunotherapy, neuropathology, neuroimaging, adult brain tumors
MeSH terms
Neurosurgeons, Adult, Glioblastoma, Humans, Practice Guidelines as Topic, Consensus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review